ProShare Advisors LLC
- SEC CIK
- 0001357955
- Latest filing
- Aug 11, 2026
CLDX holding history
Celldex Therapeutics, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLDX overviewAll 13F holders of CLDXFull Q2 2026 holdings
- Shares (Q2 2026)
- 10,237
- Value
- $380.9K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 10,237 | $380.9K | <0.1% | +744+7.8% | Added | Holders |
| Q1 2026 | 9,493 | $301.1K | <0.1% | −2,480−20.7% | Reduced | Holders |
| Q4 2025 | 11,973 | $325.2K | <0.1% | +773+6.9% | Added | Holders |
| Q3 2025 | 11,200 | $289.7K | <0.1% | −2,230−16.6% | Reduced | Holders |
| Q2 2025 | 13,430 | $273.3K | <0.1% | −556−4.0% | Reduced | Holders |
| Q1 2025 | 13,986 | $253.8K | <0.1% | −4,206−23.1% | Reduced | Holders |
| Q4 2024 | 18,192 | $459.7K | <0.1% | +5,986+49.0% | Added | Holders |
| Q3 2024 | 12,206 | $414.9K | <0.1% | +3,882+46.6% | Added | Holders |
| Q2 2024 | 8,324 | $308.1K | <0.1% | −2,842−25.5% | Reduced | Holders |
| Q1 2024 | 11,166 | $468.6K | <0.1% | +3,476+45.2% | Added | Holders |
| Q4 2023 | 7,690 | $305.0K | <0.1% | +7,690 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −6,043−100.0% | Sold out | Holders |
| Q2 2023 | 6,043 | $205.0K | <0.1% | +6,043 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −5,896−100.0% | Sold out | Holders |
| Q4 2022 | 5,896 | $262.8K | <0.1% | +5,896 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −8,628−100.0% | Sold out | Holders |
| Q1 2022 | 8,628 | $293.0K | <0.1% | −1,413−14.1% | Reduced | Holders |
| Q4 2021 | 10,041 | $388.0K | <0.1% | +4,146+70.3% | Added | Holders |
| Q3 2021 | 5,895 | $318.0K | <0.1% | −4,276−42.0% | Reduced | Holders |
| Q2 2021 | 10,171 | $340.0K | <0.1% | +10,171 | New | Holders |